Thermal field management improves patient-reported outcomes during ablation for papillary thyroid carcinoma: A retrospective cohort study

Table 3 Complications and side effects in the thermal field management and non-thermal field management groups, n (%)

Variables		Before PSM				After PSM
		TFM (n = 113)	non-TFM (n = 377)	HR (95%CI)	P value	TFM (n = 108)	non-TFM (n = 216)	HR (95%CI)	P value
Complications	Voice change	1 (0.9)	23 (6.1)	0.137 (0.018-0.963)	0.024	1 (0.9)	14 (6.5)	0.135 (0.017-0.983)	0.049
	Vomiting	0 (0.0)	1 (0.3)	-	1.000	0 (0)	0 (0)	-	-
Side effect	Pain	4 (3.5)	35 (9.3)	0.359 (0.125-0.987)	0.048	4 (3.7)	21 (9.7)	0.357 (0.119-1.068)	0.090
	Neck discomfort	2 (1.8)	10 (2.7)	0.661 (0.143-3.063)	0.594	2 (1.9)	6 (2.8)	0.660 (0.131-3.328)	0.899
	Coughing	0 (0.0)	2 (0.5)	-	1.000	0 (0)	1 (0.5)	-	1.000
	Dry mouth	4 (3.5)	26 (6.9)	0.495 (0.169-1.451)	0.192	4 (3.7)	14 (6.5)	0.555 (0.1789-1.728)	0.440
	Dysphagia	0 (0.0)	3 (0.8)	-	1.000	0 (0)	3 (1.4)	-	0.538
	Foreign body sensation	1 (0.9)	8 (2.1)	0.412 (0.051-3.328)	0.692	1 (0.9)	4 (1.9)	0.495 (0.055-4.486)	0.873
	Tachycardiac	3 (2.7)	10 (2.7)	1.001 (0.271-3.701)	0.999	3 (2.8)	6 (2.8)	1.000 (0.245-4.078)	1.000
	Tired	6 (5.3)	27 (7.2)	0.727 (0.292-1.807)	0.491	6 (5.6)	17 (7.9)	0.689 (0.263-1.800)	0.592

TFM: Thermal field management; PSM: Propensity score matching.